Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-09

FDA Approved: PROLATE — Supplemental Application (Forte Bio-Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for PROLATE, a generic oxycodone hydrochloride and acetaminophen tablet, for Forte Bio-Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROLATE (OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN)

Snippet

SUPPL AP for PROLATE (OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN)